Permeability characteristics of hemoglobin derivatives across cultured endothelial cell monolayers - PubMed (original) (raw)
Permeability characteristics of hemoglobin derivatives across cultured endothelial cell monolayers
K Nakai et al. J Lab Clin Med. 1998 Oct.
Abstract
To better understand the vascular activity of hemoglobin-based (Hb-based) oxygen carriers, the endothelial permeability characteristics of Hb derivatives having various molecular masses were defined by using monolayers of bovine endothelial cells cultured on microporous membranes. The endothelial permeability of unmodified bovine Hb was almost twice that of bovine serum albumin. Intramolecularly cross-linked human Hb showed slightly but significantly reduced permeability as compared with unmodified bovine Hb. Polyethyleneglycol modification or haptoglobin binding to Hb further reduced the permeability. These properties were intensified in conditions in which the endothelial barrier function was reduced by pretreatment with either interleukin-6 (100 ng/mL, 21 hours) or lipopolysaccharide (1 microg/mL, 10 hours). In contrast, there was little permeability of liposome-encapsulated Hb, and it was almost unaffected by the pretreatments. These data provide the first information that Hb derivatives with smaller molecular masses show larger transendothelial flux. Because Hb is a potent scavenger of endothelium-derived relaxing factor (EDRF), our observations support the idea that smaller Hb-based acellular oxygen carriers are potent vasoconstrictors as a result of abluminal EDRF scavenging.
Similar articles
- Inhibition of endothelium-dependent relaxation by hemoglobin in rabbit aortic strips: comparison between acellular hemoglobin derivatives and cellular hemoglobins.
Nakai K, Ohta T, Sakuma I, Akama K, Kobayashi Y, Tokuyama S, Kitabatake A, Nakazato Y, Takahashi TA, Sadayoshi S. Nakai K, et al. J Cardiovasc Pharmacol. 1996 Jul;28(1):115-23. doi: 10.1097/00005344-199607000-00018. J Cardiovasc Pharmacol. 1996. PMID: 8797145 - Quantitative assessment of hemoglobin-induced endothelial barrier dysfunction.
Dull RO, DeWitt BJ, Dinavahi R, Schwartz L, Hubert C, Pace N, Fronticelli C. Dull RO, et al. J Appl Physiol (1985). 2004 Nov;97(5):1930-7. doi: 10.1152/japplphysiol.00102.2004. Epub 2004 Jul 23. J Appl Physiol (1985). 2004. PMID: 15273237 - Endothelium-derived relaxing factor contributes to the regulation of endothelial permeability.
Oliver JA. Oliver JA. J Cell Physiol. 1992 Jun;151(3):506-11. doi: 10.1002/jcp.1041510309. J Cell Physiol. 1992. PMID: 1363553 - Modulation of venular microvessel permeability by calcium influx into endothelial cells.
Curry FE. Curry FE. FASEB J. 1992 Apr;6(7):2456-66. doi: 10.1096/fasebj.6.7.1563597. FASEB J. 1992. PMID: 1563597 Review. - How Nitric Oxide Hindered the Search for Hemoglobin-Based Oxygen Carriers as Human Blood Substitutes.
Samaja M, Malavalli A, Vandegriff KD. Samaja M, et al. Int J Mol Sci. 2023 Oct 4;24(19):14902. doi: 10.3390/ijms241914902. Int J Mol Sci. 2023. PMID: 37834350 Free PMC article. Review.
Cited by
- Haem oxygenase shows pro-oxidant activity in microsomal and cellular systems: implications for the release of low-molecular-mass iron.
Lamb NJ, Quinlan GJ, Mumby S, Evans TW, Gutteridge JM. Lamb NJ, et al. Biochem J. 1999 Nov 15;344 Pt 1(Pt 1):153-8. Biochem J. 1999. PMID: 10548545 Free PMC article. - Haptoglobin, hemopexin, and related defense pathways-basic science, clinical perspectives, and drug development.
Schaer DJ, Vinchi F, Ingoglia G, Tolosano E, Buehler PW. Schaer DJ, et al. Front Physiol. 2014 Oct 28;5:415. doi: 10.3389/fphys.2014.00415. eCollection 2014. Front Physiol. 2014. PMID: 25389409 Free PMC article. Review. - Sequestration of extracellular hemoglobin within a haptoglobin complex decreases its hypertensive and oxidative effects in dogs and guinea pigs.
Boretti FS, Buehler PW, D'Agnillo F, Kluge K, Glaus T, Butt OI, Jia Y, Goede J, Pereira CP, Maggiorini M, Schoedon G, Alayash AI, Schaer DJ. Boretti FS, et al. J Clin Invest. 2009 Aug;119(8):2271-80. doi: 10.1172/JCI39115. Epub 2009 Jul 20. J Clin Invest. 2009. PMID: 19620788 Free PMC article. - Hemoglobin-driven pathophysiology is an in vivo consequence of the red blood cell storage lesion that can be attenuated in guinea pigs by haptoglobin therapy.
Baek JH, D'Agnillo F, Vallelian F, Pereira CP, Williams MC, Jia Y, Schaer DJ, Buehler PW. Baek JH, et al. J Clin Invest. 2012 Apr;122(4):1444-58. doi: 10.1172/JCI59770. Epub 2012 Mar 26. J Clin Invest. 2012. PMID: 22446185 Free PMC article. - Human Hp1-1 and Hp2-2 phenotype-specific haptoglobin therapeutics are both effective in vitro and in guinea pigs to attenuate hemoglobin toxicity.
Lipiski M, Deuel JW, Baek JH, Engelsberger WR, Buehler PW, Schaer DJ. Lipiski M, et al. Antioxid Redox Signal. 2013 Nov 10;19(14):1619-33. doi: 10.1089/ars.2012.5089. Epub 2013 Mar 28. Antioxid Redox Signal. 2013. PMID: 23418677 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous